Circulating Bcl-2 concentrations and septic patient mortality
- 1 August 2021
- journal article
- research article
- Published by Elsevier in Enfermedades Infecciosas y Microbiología Clínica
- Vol. 39 (7) , 330-334
Abstract
No abstract availableKeywords
Funding Information
- European Regional Development Fund (PI-18-00500)
- Instituto de Salud Carlos III (PI-18-00500)
This publication has 19 references indexed in Scilit:
- Different changes in mitochondrial apoptotic pathway in lymphocytes and granulocytes in cirrhotic patients with sepsisLiver International, 2013
- Is Suppression of Apoptosis a New Therapeutic Target in Sepsis?Anaesthesia and Intensive Care, 2013
- Molecular Mechanisms Underlying Delayed Apoptosis in Neutrophils from Multiple Trauma Patients with and without SepsisMolecular Medicine, 2011
- Post-operative infection and sepsis in humans is associated with deficient gene expression of γccytokines and their apoptosis mediatorsCritical Care, 2011
- Induction of Bim and Bid gene expression during accelerated apoptosis in severe sepsisCritical Care, 2008
- The Apoptotic Pathway as a Therapeutic Target in SepsisCurrent Drug Targets, 2007
- Sepsis in European intensive care units: Results of the SOAP study*Critical Care Medicine, 2006
- Apoptosis-based therapies and drug targetsCell Death & Differentiation, 2005
- Transient Bcl-2 gene down-expression in circulating mononuclear cells of severe sepsis patients who died despite appropriate intensive careIntensive Care Medicine, 2004
- Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of careCritical Care Medicine, 2001